Showing results (21-30 of 453) with videos related to
Sort By:
Pageof 46
CPT: Pharmacometrics & Systems Pharmacology|June 24, 2017
A Longitudinal Item Response Theory Model to Characterize Cognition Over Time in Elderly SubjectsMarc Vandemeulebroecke, Björn Bornkamp, Tillmann Krahnke, et al.Pharmaceutical Statistics|September 23, 2009
The application of bespoke spending functions in group-sequential designs and the effect of delayed treatment switching in survival trialsAndrew StoneJournal of Biopharmaceutical Statistics|November 9, 2010
Comments on the draft guidance on "adaptive design clinical trials for drugs and biologics" of the U.S. Food and Drug AdministrationWerner Brannath, Hans Ulrich Burger, Ekkehard Glimm, et al.Pharmaceutical Statistics|November 1, 2018
How can we make better graphs? An initiative to increase the graphical expertise and productivity of quantitative scientistsMarc Vandemeulebroecke, Mark Baillie, David Carr, et al.Stroke|September 30, 2006
Medium-term variability of blood pressure and potential underdiagnosis of hypertension in patients with previous transient ischemic attack or minor strokeRobert L Cuffe, Sally C Howard, Ale Algra, et al.Archives of Orthopaedic and Trauma Surgery|August 2, 2021
Instability and results after non-operative treatment of large anterior glenoid rim fractures: is there a correlation between fragment size or displacement and recurrence?Matthias Königshausen, Simon Pätzholz, Marlon Coulibaly, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 5, 2022
Lower Limbs are the Most Difficult-to-Treat Body Region of Patients with Psoriasis: Pooled Analysis of CLEAR and CLARITY Studies of Secukinumab Versus Ustekinumab by Body RegionMiguel Alpalhão, Joana Duarte, Rita Diogo, et al.Statistical Methods in Medical Research|September 10, 2010
Multiplicity adjustments in trials with two correlated comparisons of interestNikki Fernandes, Andrew StonePharmaceutical Statistics|May 10, 2014
Can a treatment be licenced on the basis of post-treatment predictive biomarkers?Andrew Stone, Nicola SchmittRMD Open|June 15, 2023
Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritisMathias Cardner, Danny Tuckwell, Anna Kostikova, et al.Pageof 46